Ιoannis Kotsianidis

Democritus University of Thrace — Greece

Medicine · Health Sciences

31h-index5.2kcitations323works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(154), Myeloproliferative Neoplasms: Diagnosis and Treatment(68), Chronic Myeloid Leukemia Treatments(39), Chronic Lymphocytic Leukemia Research(38), Lymphoma Diagnosis and Treatment(33)

Publications323 total

Hans-Based Cell of Origin Is Not of Prognostic Significance in Diffuse Large B-Cell Lymphoma Patients: A Retrospective Single-Center Study Conducted in 326 RCHOP-Treated Patients
Acta Haematologica·2025
Siltuximab monotherapy improves progression free survival compared to rituximab-based therapies in patients with idiopathic multicentric Castleman disease; indirect comparison of studies using single-arm metanalysis method and the generalized linear mixed model
Annals of Hematology·2025Open Access
Clinical implications of TP53 mutations (TP53MT) in patients (pts) with higher risk Myelodysplastic Syndromes (HR-MDS) treated with hypomethylating agents (HMA) and allogeneic hematopoietic transplantation (allo-HCT): An analysis from the international consortium of MDS (icMDS) validate database
Blood·2025Open Access
Personalized Prediction of the Time to Loss of Response to Azacytidine in MDS Patients
Sci·2025Open Access
Identification of novel predictors of cardiovascular disease risk in MDS patients: Results of a prospective observational single-centre cohort study
Blood·2025Open Access
Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.
Blood·2025
The prognostic significance (or lack) of achieving marrow complete remission (mCR) with hypomethylating agent-based therapy in patients with myelodysplastic syndrome
Blood·2025
Treatment with luspatersept exerts a pleiotropic effect on the molecular signatures of bone marrow cell subsets
Blood·2025Open Access
Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.
Blood·2025Open Access
Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database
Blood·2025Open Access
Wide variability and inconsistency in reporting of results of Myelodysplastic Syndromes/neoplasms (MDS) clinical trials: An icMDS systematic review of published manuscripts
Blood·2025Open Access
Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL
Blood Advances·2025Open Access
Applications of Multiparameter Flow Cytometry in the Diagnosis, Prognosis, and Monitoring of Multiple Myeloma Patients
Diseases·2025· 2 citedOpen Access
PLENARY SESSION 08: TREATMENT HIGH RISK
Leukemia Research·2025
PROGNOSIS - PREDICTIVE FACTORS OF RESPONSE TO TREATMENT
Leukemia Research·2025
PROGNOSIS - PROGNOSTIC FACTORS OF OUTCOME AND RISK ASSESSMENT
Leukemia Research·2025Open Access
Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration
Annals of Hematology·2025Open Access
Applications of Multiparameter Flow Cytometry in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma Patients
Preprints.org·2025Open Access
Comparative Analysis of the TCR Repertoire in Bone Marrow CD8 <sup>+</sup> T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia
European Journal of Immunology·2025Open Access
Author response for "Comparative Analysis of the TCR Repertoire in Bone Marrow CD8&lt;SUP&gt;+&lt;/SUP&gt; T Cells From Patients With Acute Myeloid Leukemia, Myelodysplastic Neoplasms, and Chronic Myelomonocytic Leukemia"
2025
page 1 of 17Next →

Frequent Co-authors

Pierre Fenaux(10), Argiris Symeonidis(10), Guillermo Sanz(9), Luca Malcovati(9), Emmanouil Spanoudakis(9), Ulrich Germing(8), Eleftheria Lamprianidou(8), Costas Tsatalas(7), Anastasios Karadimitris(7), Helen Α. Papadaki(7), Sotirios G. Papageorgiou(7), Elsa Bernard(6), Lionel Adès(6), Valeria Santini(6), Eva Hellström‐Lindberg(6), Panayiotis Panayiotidis(6), Theodoros P. Vassilakopoulos(6), Peter L. Greenberg(5), Robert P. Hasserjian(5), Maria Creignou(5)